Article
The clinical utility of biomarkers in the management of pancreatic adenocarcinoma.
Seminars in radiation oncology - 1 Apr 2014
Jazieh Khalid A, Foote Michael B, Diaz Luis A
Abstract excerpt
Pancreatic cancer is the fourth leading cause of cancer-related deaths in the United States and survival rates have seen minimal improvement over the past few decades. Although results are poor, surgical resection is considered the only curative therapeutic intervention for pancreatic cancer, thereby emphasizing the significance of effective diagnostic and prognostic tools to improve outcomes. As such, biomarkers...
Topics
- Adenocarcinoma
- Animals
- Biomarkers, Tumor
- Genetic Markers
- Genetic Predisposition to Disease
- Humans
- Neoplastic Stem Cells
- Pancreatic Neoplasms
- Prognosis